ADH1 Pep-LNP

Name: ADH1 Pep-LNP
SKU: TDLD-0126-LD60
Rating: 5 (1 reviews)

Cat. No.: TDLD-0126-LD60

ADH1 Pep-LNP

ADH1 Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) engineered with ADH1 Peptide, designed for efficient targeted delivery of therapeutic cargoes. It enables active targeted delivery through ADH1-mediated recognition, offering enhanced solubility and prolonged circulation. Applications include developing targeted therapeutics and studying ADH1 biology. Please note that this product is intended for research purposes only.

Inquiry

SPECIFIC INQUIRY

Payload:

Modification:

Lipid Formulation:

Dye:

Concentration:

Quantity:

Clear All Inquiry

For Research Use Only. Not for Diagnostic or Treatment Applications.

Payload Type	mRNA
Payload	Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others
Capping	Cap 1
Modification	Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other

Module Type	Peptide
Targeting Module	ADH1 Peptide

Target	ADH1 receptor
Lipid Formulation	DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other
Dye	Unlabeled; DiR; DiD; DiO; DiI; Other
Application	Control; Targeted Delivery; Gene Therapy
Format	Liquid
Concentration	0.1 mg/mL; 0.2 mg/mL; Other (Please Specify)

Size	65-120 nm
PDI	< 0.2
Zeta	± 20.0 mV
Encapsulate Efficiency	>90%

Shipping	Dry Ice
Storage	Store at -80°C